LLY

981.29

-2.24%↓

JNJ

239.53

-2.3%↓

ABBV

232.07

-1.66%↓

NVS

160.95

-2.49%↓

AZN

197.36

-2.11%↓

LLY

981.29

-2.24%↓

JNJ

239.53

-2.3%↓

ABBV

232.07

-1.66%↓

NVS

160.95

-2.49%↓

AZN

197.36

-2.11%↓

LLY

981.29

-2.24%↓

JNJ

239.53

-2.3%↓

ABBV

232.07

-1.66%↓

NVS

160.95

-2.49%↓

AZN

197.36

-2.11%↓

LLY

981.29

-2.24%↓

JNJ

239.53

-2.3%↓

ABBV

232.07

-1.66%↓

NVS

160.95

-2.49%↓

AZN

197.36

-2.11%↓

LLY

981.29

-2.24%↓

JNJ

239.53

-2.3%↓

ABBV

232.07

-1.66%↓

NVS

160.95

-2.49%↓

AZN

197.36

-2.11%↓

Search

Kala Pharmaceuticals Inc

Gesloten

0.23 -32.35

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

0.23

Max

0.34

Belangrijke statistieken

By Trading Economics

Inkomsten

3.6M

-7.6M

Dividenden

By Dow Jones

Volgende Winsten

30 mrt 2026

Kala Pharmaceuticals Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

5 mrt 2026, 23:01 UTC

Winsten

Costco Evaluating Possibility of Tariff Refunds as 2Q Revenue Rises - Update

5 mrt 2026, 21:54 UTC

Winsten

Costco Posts Higher 2Q Profit on Rising Sales, Membership Fees

5 mrt 2026, 21:35 UTC

Belangrijke Marktbewegers

ServiceNow Shares Rise After CEO Says AI Can Add Value to Software

6 mrt 2026, 00:00 UTC

Belangrijke Nieuwsgebeurtenissen

Its Missile Threat Degraded, Iran Is Taking Fewer Shots at More Targets -- WSJ

5 mrt 2026, 23:46 UTC

Marktinformatie

Nikkei May Decline Amid Concerns About Energy Costs -- Market Talk

5 mrt 2026, 23:33 UTC

Marktinformatie

Gold Edges Higher on Possible Technical Recovery -- Market Talk

5 mrt 2026, 23:27 UTC

Marktinformatie

Middle East Fighting Will Prompt RBA to Delay Hike -- Market Talk

5 mrt 2026, 22:54 UTC

Marktinformatie
Winsten

Costco Sold a $150,000 Diamond Ring in 2Q -- Market Talk

5 mrt 2026, 22:50 UTC

Marktinformatie

Woodside Has More Exposure to Rising Gas Prices Than Santos -- Market Talk

5 mrt 2026, 22:48 UTC

Winsten

Nike Reports $300 Million Pretax Charge Related to Job Cuts -- Barrons.com

5 mrt 2026, 22:46 UTC

Winsten

Costco Evaluating Possibility of Tariff Refunds as 2Q Revenue Rises -- Update

5 mrt 2026, 22:44 UTC

Winsten

Costco Earnings Beat Expectations as Membership Model Shines -- Barrons.com

5 mrt 2026, 21:50 UTC

Marktinformatie

Tech, Media & Telecom Roundup: Market Talk

5 mrt 2026, 21:50 UTC

Marktinformatie

Financial Services Roundup: Market Talk

5 mrt 2026, 21:50 UTC

Marktinformatie

Health Care Roundup: Market Talk

5 mrt 2026, 21:35 UTC

Winsten

Marvell Earnings Beat Estimates on 'Robust' AI Demand. The Stock Jumps. -- Barrons.com

5 mrt 2026, 21:32 UTC

Winsten

Costco Earnings Beat Expectations as Membership Model Shines -- Barrons.com

5 mrt 2026, 21:26 UTC

Winsten

These Stocks Are Today's Movers: Broadcom, Trade Desk, Berkshire Hathaway, Rigetti, Corning, Ciena, Expedia, and More -- Barrons.com

5 mrt 2026, 21:24 UTC

Winsten

Costco February Digitally-Enabled Sales Ex-Changes in Gas and Foreign Exchange Rose 20.8% >COST

5 mrt 2026, 21:23 UTC

Winsten

Costco February Same-Store Sales Ex-Changes in Gas and Foreign Exchange Rose 7% >COST

5 mrt 2026, 21:22 UTC

Winsten

Costco 2Q Same-Store Sales Ex-Changes in Gas and Foreign Rose 6.7% >COST

5 mrt 2026, 21:21 UTC

Winsten

Costco February Digitally-Enabled Sales Rose 21.8% >COST

5 mrt 2026, 21:21 UTC

Winsten

Costco Total Co Comparable Sales for February Rose 7.9% >COST

5 mrt 2026, 21:20 UTC

Winsten

Costco February Net Sales Were $21.69 B >COST

5 mrt 2026, 21:20 UTC

Winsten

Marvell Earnings Beat Estimates on 'Robust' AI Demand. The Stock Jumps. -- Barrons.com

5 mrt 2026, 21:20 UTC

Winsten

Costco Same-Store Sales Ex-Changes in Gas and Foreign Rose 6.7% >COST

5 mrt 2026, 21:19 UTC

Winsten

Costco 2Q Digitally-Enabled Sales Ex-Changes in Gas and Foreign Exchange Rose 21.7% >COST

5 mrt 2026, 21:18 UTC

Winsten

Costco 2Q Digitally-Enabled Sales Rose 22.6% >COST

5 mrt 2026, 21:18 UTC

Winsten

Costco 2Q Same-Store Sales Up 7.4% >COST

5 mrt 2026, 21:15 UTC

Winsten

Costco 2Q EPS $4.58 >COST

Peer Vergelijking

Prijswijziging

Kala Pharmaceuticals Inc Prognose

Beoordelingsconsensus

By TipRanks

0 ratings

0

Buy

0

Hold

0

Sell

Financieel

Verkoop- en administratiekosten

Winst voor belastingen

Verkoop

Rente-uitgaven op schulden

Operationele winst

$

Over Kala Pharmaceuticals Inc

Kala Pharmaceuticals Inc
help-icon Live chat